2019 annual financial data
Nektar Therapeutics 2019 Operating margin
Nektar Therapeutics 2019 operating margin with verified reported values.
Direct answer
Operating margin was -383.92%.
Operating income was -440,035,000 USD and net income was -440,667,000 USD.
Operating cash flow was -328,681,000 USD.
Get free Nektar Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 114,617,000 USD
- Operating income
- -440,035,000 USD
- Net income
- -440,667,000 USD
- Operating cash flow
- -328,681,000 USD